Official recall notice

FDA DrugClass IINotable

FDA Recall: GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthca

Recall date
2026-04-15
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Presence of particulate matter

Recommended action

What to do

866,570 vials

Product description

Presence of particulate matter

Verify with the official notice →
Share:

Related Recalls

2026-09-21 · FDA_DRUG
FDA Recall: Par Pharmaceutical: Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL)
Par Pharmaceutical
2026-09-21 · FDA_DRUG
FDA Recall: ICU Medical LLC: 0.9% Sodium Chloride Injection, USP, 100 mL
ICU Medical LLC
2026-09-16 · FDA_DRUG
FDA Recall: Povidone Iodine 1.25% / Proparacaine HCl 0.5% Ophthalmic Solution, 10 mL per dropper bottle, For Off
ImprimisRx NJ LLC
2026-09-16 · FDA_DRUG
FDA Recall: Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharm
Ajanta Pharma USA Inc